Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 248

1.

Inhibition of calcium-calmodulin-dependent phosphodiesterase (PDE1) suppresses inflammatory responses.

O'Brien JJ, O'Callaghan JP, Miller DB, Chalgeri S, Wennogle LP, Davis RE, Snyder GL, Hendrick JP.

Mol Cell Neurosci. 2020 Jan;102:103449. doi: 10.1016/j.mcn.2019.103449. Epub 2019 Nov 23.

2.

Is What You See What You Get? Perceptions of Personal Trainers' Competence, Knowledge, and Preferred Sex of Personal Trainer Relative to Physique.

Boerner PR, Polasek KM, True L, Lind E, Hendrick JL.

J Strength Cond Res. 2019 Mar 18. doi: 10.1519/JSC.0000000000003027. [Epub ahead of print]

PMID:
30893281
3.

Gabapentin and Tricyclics in the Treatment of Post-Concussive Headache, a Retrospective Cohort Study.

Cushman DM, Borowski L, Hansen C, Hendrick J, Bushman T, Teramoto M.

Headache. 2019 Mar;59(3):371-382. doi: 10.1111/head.13451. Epub 2018 Nov 19.

PMID:
30451286
4.

Acute Enhancement of Cardiac Function by Phosphodiesterase Type 1 Inhibition.

Hashimoto T, Kim GE, Tunin RS, Adesiyun T, Hsu S, Nakagawa R, Zhu G, O'Brien JJ, Hendrick JP, Davis RE, Yao W, Beard D, Hoxie HR, Wennogle LP, Lee DI, Kass DA.

Circulation. 2018 Oct 30;138(18):1974-1987. doi: 10.1161/CIRCULATIONAHA.117.030490.

5.

Reliability of the balance error scoring system in a population with protracted recovery from mild traumatic brain injury.

Cushman D, Hendrick J, Teramoto M, Fogg B, Bradley S, Hansen C.

Brain Inj. 2018;32(5):569-574. doi: 10.1080/02699052.2018.1432891. Epub 2018 Feb 2.

PMID:
29393686
6.

Genetic panel sequencing for advanced stage cancer disease in the clinic.

Hilke F, Schroeder C, Doehring A, Faust U, Forschner A, Hartkopf A, Schittenhelm M, Brecht I, Hendrick J, Riess O.

Ann Oncol. 2017 Oct;28 Suppl 7:vii17. doi: 10.1093/annonc/mdx511.011. No abstract available.

7.

Phosphodiesterase 1: A Unique Drug Target for Degenerative Diseases and Cognitive Dysfunction.

Wennogle LP, Hoxie H, Peng Y, Hendrick JP.

Adv Neurobiol. 2017;17:349-384. doi: 10.1007/978-3-319-58811-7_13. Review.

PMID:
28956339
8.

Peculiar citric acid cycle of hydrothermal vent chemolithoautotroph Hydrogenovibrio crunogenus, and insights into carbon metabolism by obligate autotrophs.

Quasem I, Achille AN, Caddick BA, Carter TA, Daniels C, Delaney JA, Delic V, Denton KA, Duran MC, Fatica MK, Ference CM, Galkiewicz JP, Garcia AM, Hendrick JD, Horton SA, Kun MS, Koch PW, Lee TM, McCabe CR, McHale S, McDaniel LD, Menning DM, Menning KJ, Mirzaei-Souderjani H, Mostajabian S, Nicholson DA, Nugent CK, Osman NP, Pappas DI, Rocha AM, Rosario K, Rubelmann H, Schwartz JA, Seeley KW, Staley CM, Wallace EM, Wong TM, Zielinski BL, Hanson TE, Scott KM.

FEMS Microbiol Lett. 2017 Aug 1;364(14). doi: 10.1093/femsle/fnx148.

PMID:
28854673
9.

Spatial Rho regulation: Molecular mechanisms controlling the GAP protein DLC3.

Hendrick J, Olayioye MA.

Small GTPases. 2019 Jan;10(1):13-19. doi: 10.1080/21541248.2016.1260673. Epub 2016 Dec 21.

10.

The polarity protein Scribble positions DLC3 at adherens junctions to regulate Rho signaling.

Hendrick J, Franz-Wachtel M, Moeller Y, Schmid S, Macek B, Olayioye MA.

J Cell Sci. 2016 Oct 1;129(19):3583-3596. Epub 2016 Aug 5.

11.

Oncogenic Ras triggers hyperproliferation and impairs polarized colonic morphogenesis by autocrine ErbB3 signaling.

Möller Y, Morkel M, Schmid J, Beyes S, Hendrick J, Strotbek M, Riemer P, Schmid S, Schmitt LC, Kontermann R, Mürdter T, Schwab M, Sers C, Olayioye MA.

Oncotarget. 2016 Aug 16;7(33):53526-53539. doi: 10.18632/oncotarget.10658.

12.

Preclinical profile of ITI-214, an inhibitor of phosphodiesterase 1, for enhancement of memory performance in rats.

Snyder GL, Prickaerts J, Wadenberg ML, Zhang L, Zheng H, Yao W, Akkerman S, Zhu H, Hendrick JP, Vanover KE, Davis R, Li P, Mates S, Wennogle LP.

Psychopharmacology (Berl). 2016 Sep;233(17):3113-24. doi: 10.1007/s00213-016-4346-2. Epub 2016 Jun 24.

13.

Discovery of Potent and Selective Inhibitors of Phosphodiesterase 1 for the Treatment of Cognitive Impairment Associated with Neurodegenerative and Neuropsychiatric Diseases.

Li P, Zheng H, Zhao J, Zhang L, Yao W, Zhu H, Beard JD, Ida K, Lane W, Snell G, Sogabe S, Heyser CJ, Snyder GL, Hendrick JP, Vanover KE, Davis RE, Wennogle LP.

J Med Chem. 2016 Feb 11;59(3):1149-64. doi: 10.1021/acs.jmedchem.5b01751. Epub 2016 Feb 2.

PMID:
26789933
14.

Cognitive influence of a 5-h ENERGY® shot: Are effects perceived or real?

Buckenmeyer PJ, Bauer JA, Hokanson JF, Hendrick JL.

Physiol Behav. 2015 Dec 1;152(Pt A):323-7. doi: 10.1016/j.physbeh.2015.09.003. Epub 2015 Sep 21.

PMID:
26394126
15.

The Rho-specific GAP protein DLC3 coordinates endocytic membrane trafficking.

Braun AC, Hendrick J, Eisler SA, Schmid S, Hausser A, Olayioye MA.

J Cell Sci. 2015 Apr 1;128(7):1386-99. doi: 10.1242/jcs.163857. Epub 2015 Feb 11.

16.

Functional profile of a novel modulator of serotonin, dopamine, and glutamate neurotransmission.

Snyder GL, Vanover KE, Zhu H, Miller DB, O'Callaghan JP, Tomesch J, Li P, Zhang Q, Krishnan V, Hendrick JP, Nestler EJ, Davis RE, Wennogle LP, Mates S.

Psychopharmacology (Berl). 2015 Feb;232(3):605-21. doi: 10.1007/s00213-014-3704-1. Epub 2014 Aug 15.

17.

Discovery of a tetracyclic quinoxaline derivative as a potent and orally active multifunctional drug candidate for the treatment of neuropsychiatric and neurological disorders.

Li P, Zhang Q, Robichaud AJ, Lee T, Tomesch J, Yao W, Beard JD, Snyder GL, Zhu H, Peng Y, Hendrick JP, Vanover KE, Davis RE, Mates S, Wennogle LP.

J Med Chem. 2014 Mar 27;57(6):2670-82. doi: 10.1021/jm401958n. Epub 2014 Mar 5.

PMID:
24559051
18.

CAPE: an R package for combined analysis of pleiotropy and epistasis.

Tyler AL, Lu W, Hendrick JJ, Philip VM, Carter GW.

PLoS Comput Biol. 2013 Oct;9(10):e1003270. doi: 10.1371/journal.pcbi.1003270. Epub 2013 Oct 24.

19.

Muscarinic receptors acting at pre- and post-synaptic sites differentially regulate dopamine/DARPP-32 signaling in striatonigral and striatopallidal neurons.

Kuroiwa M, Hamada M, Hieda E, Shuto T, Sotogaku N, Flajolet M, Snyder GL, Hendrick JP, Fienberg A, Nishi A.

Neuropharmacology. 2012 Dec;63(7):1248-57. doi: 10.1016/j.neuropharm.2012.07.046. Epub 2012 Aug 7.

PMID:
22971543
20.

Gamma-secretase activating protein is a therapeutic target for Alzheimer's disease.

He G, Luo W, Li P, Remmers C, Netzer WJ, Hendrick J, Bettayeb K, Flajolet M, Gorelick F, Wennogle LP, Greengard P.

Nature. 2010 Sep 2;467(7311):95-8. doi: 10.1038/nature09325.

21.

Nerve agent exposure elicits site-specific changes in protein phosphorylation in mouse brain.

Zhu H, O'Brien JJ, O'Callaghan JP, Miller DB, Zhang Q, Rana M, Tsui T, Peng Y, Tomesch J, Hendrick JP, Wennogle LP, Snyder GL.

Brain Res. 2010 Jun 25;1342:11-23. doi: 10.1016/j.brainres.2010.04.034. Epub 2010 Apr 25.

22.

Caspase inhibition modulates left ventricular remodeling following myocardial infarction through cellular and extracellular mechanisms.

Yarbrough WM, Mukherjee R, Stroud RE, Meyer EC, Escobar GP, Sample JA, Hendrick JW, Mingoia JT, Spinale FG.

J Cardiovasc Pharmacol. 2010 Apr;55(4):408-16. doi: 10.1097/FJC.0b013e3181d4ca66.

23.

Hands-free versus hand-held cell phone conversation on a braking response by young drivers.

Hendrick JL, Switzer JR.

Percept Mot Skills. 2007 Oct;105(2):514-22.

PMID:
18065072
24.

General anesthetics selectively modulate glutamatergic and dopaminergic signaling via site-specific phosphorylation in vivo.

Snyder GL, Galdi S, Hendrick JP, Hemmings HC Jr.

Neuropharmacology. 2007 Oct;53(5):619-30. Epub 2007 Jul 24.

PMID:
17826804
25.

Discovery of (S)-2-((S)-2-(3,5-difluorophenyl)-2-hydroxyacetamido)-N-((S,Z)-3-methyl-4-oxo-4,5-dihydro-3H-benzo[d][1,2]diazepin-5-yl)propanamide (BMS-433796): a gamma-secretase inhibitor with Abeta lowering activity in a transgenic mouse model of Alzheimer's disease.

Prasad CV, Zheng M, Vig S, Bergstrom C, Smith DW, Gao Q, Yeola S, Polson CT, Corsa JA, Guss VL, Loo A, Wang J, Sleczka BG, Dangler C, Robertson BJ, Hendrick JP, Roberts SB, Barten DM.

Bioorg Med Chem Lett. 2007 Jul 15;17(14):4006-11. Epub 2007 Apr 30.

PMID:
17502137
26.

Evaluation of neuronal phosphoproteins as effectors of caffeine and mediators of striatal adenosine A2A receptor signaling.

Sahin B, Galdi S, Hendrick J, Greene RW, Snyder GL, Bibb JA.

Brain Res. 2007 Jan 19;1129(1):1-14. Epub 2006 Dec 6.

27.

Comparing no-touch and tympanic thermometer temperature recordings.

Woodrow P, May V, Buras-Rees S, Higgs D, Hendrick J, Lewis T, Whitney S, Cummings C, Boorman P, O'Donnell A, Harris P, McHenry M.

Br J Nurs. 2006 Oct 12-25;15(18):1012-6.

PMID:
17077774
28.

Differential effects of protein kinase C isoform activation in endothelin-mediated myocyte contractile dysfunction with cardioplegic arrest and reperfusion.

Apple KA, McLean JE, Squires CE, Schaeffer B, Sample JA, Murphy RL, Deschamps AM, Leonardi AH, Allen CM, Hendrick JW, Stroud RE, Mukherjee R, Spinale FG.

Ann Thorac Surg. 2006 Aug;82(2):664-71.

PMID:
16863782
29.

Matrix metalloproteinase-7 affects connexin-43 levels, electrical conduction, and survival after myocardial infarction.

Lindsey ML, Escobar GP, Mukherjee R, Goshorn DK, Sheats NJ, Bruce JA, Mains IM, Hendrick JK, Hewett KW, Gourdie RG, Matrisian LM, Spinale FG.

Circulation. 2006 Jun 27;113(25):2919-28. Epub 2006 Jun 12.

PMID:
16769909
30.

Chronic matrix metalloproteinase inhibition following myocardial infarction in mice: differential effects on short and long-term survival.

Spinale FG, Escobar GP, Hendrick JW, Clark LL, Camens SS, Mingoia JP, Squires CG, Stroud RE, Ikonomidis JS.

J Pharmacol Exp Ther. 2006 Sep;318(3):966-73. Epub 2006 Jun 6.

PMID:
16757539
31.

QCT versus DXA in 320 survivors of childhood cancer: association of BMD with fracture history.

Kaste SC, Tong X, Hendrick JM, Karimova EJ, Srivastava DK, Tylavsky FA, Snider TL, Carbone LD.

Pediatr Blood Cancer. 2006 Dec;47(7):936-43.

PMID:
16602115
32.

Selective targeting of matrix metalloproteinase inhibition in post-infarction myocardial remodeling.

Apple KA, Yarbrough WM, Mukherjee R, Deschamps AM, Escobar PG, Mingoia JT, Sample JA, Hendrick JW, Dowdy KB, McLean JE, Stroud RE, O'Neill TP, Spinale FG.

J Cardiovasc Pharmacol. 2006 Feb;47(2):228-35.

PMID:
16495760
33.

A multidimensional proteomic approach to identify hypertrophy-associated proteins.

Lindsey ML, Goshorn DK, Comte-Walters S, Hendrick JW, Hapke E, Zile MR, Schey K.

Proteomics. 2006 Apr;6(7):2225-35.

PMID:
16493702
34.

Abdominal compartment syndrome in a newly diagnosed patient with Burkitt lymphoma.

Hendrick JM, Kaste SC, Tamburro RF, Hoffer FA, Onciu M, Sandlund JT, Ribeiro RC, Chandler JC, Howard SC.

Pediatr Radiol. 2006 Mar;36(3):254-7. Epub 2006 Jan 5.

PMID:
16395547
35.

Regulation of phosphorylation of the GluR1 AMPA receptor by dopamine D2 receptors.

Håkansson K, Galdi S, Hendrick J, Snyder G, Greengard P, Fisone G.

J Neurochem. 2006 Jan;96(2):482-8. Epub 2005 Dec 8.

36.

Cardiac support device modifies left ventricular geometry and myocardial structure after myocardial infarction.

Blom AS, Mukherjee R, Pilla JJ, Lowry AS, Yarbrough WM, Mingoia JT, Hendrick JW, Stroud RE, McLean JE, Affuso J, Gorman RC, Gorman JH 3rd, Acker MA, Spinale FG.

Circulation. 2005 Aug 30;112(9):1274-83.

PMID:
16129812
37.

An inhibitor binding pocket distinct from the catalytic active site on human beta-APP cleaving enzyme.

Kornacker MG, Lai Z, Witmer M, Ma J, Hendrick J, Lee VG, Riexinger DJ, Mapelli C, Metzler W, Copeland RA.

Biochemistry. 2005 Aug 30;44(34):11567-73.

PMID:
16114893
38.

Nicotine regulates DARPP-32 (dopamine- and cAMP-regulated phosphoprotein of 32 kDa) phosphorylation at multiple sites in neostriatal neurons.

Hamada M, Hendrick JP, Ryan GR, Kuroiwa M, Higashi H, Tanaka M, Nairn AC, Greengard P, Nishi A.

J Pharmacol Exp Ther. 2005 Nov;315(2):872-8. Epub 2005 Jul 22.

PMID:
16040813
39.

Age-dependent changes in myocardial matrix metalloproteinase/tissue inhibitor of metalloproteinase profiles and fibroblast function.

Lindsey ML, Goshorn DK, Squires CE, Escobar GP, Hendrick JW, Mingoia JT, Sweterlitsch SE, Spinale FG.

Cardiovasc Res. 2005 May 1;66(2):410-9. Epub 2004 Dec 13.

PMID:
15820210
40.

Accelerated LV remodeling after myocardial infarction in TIMP-1-deficient mice: effects of exogenous MMP inhibition.

Ikonomidis JS, Hendrick JW, Parkhurst AM, Herron AR, Escobar PG, Dowdy KB, Stroud RE, Hapke E, Zile MR, Spinale FG.

Am J Physiol Heart Circ Physiol. 2005 Jan;288(1):H149-58.

41.

Caspase inhibition attenuates contractile dysfunction following cardioplegic arrest and rewarming in the setting of left ventricular failure.

Yarbrough WM, Mukherjee R, Squires CE, Reese ES, Leiser JS, Stroud RE, Sample JA, Hendrick JW, Mingoia JT, McLean JE, Hardin AE, Dowdy KB, Spinale FG.

J Cardiovasc Pharmacol. 2004 Dec;44(6):645-50.

PMID:
15550782
42.

Dynamics of {beta}-amyloid reductions in brain, cerebrospinal fluid, and plasma of {beta}-amyloid precursor protein transgenic mice treated with a {gamma}-secretase inhibitor.

Barten DM, Guss VL, Corsa JA, Loo A, Hansel SB, Zheng M, Munoz B, Srinivasan K, Wang B, Robertson BJ, Polson CT, Wang J, Roberts SB, Hendrick JP, Anderson JJ, Loy JK, Denton R, Verdoorn TA, Smith DW, Felsenstein KM.

J Pharmacol Exp Ther. 2005 Feb;312(2):635-43. Epub 2004 Sep 27.

PMID:
15452193
43.

Myocyte contractility with caspase inhibition and simulated hyperkalemic cardioplegic arrest.

Mukherjee R, Yarbrough WM, Reese ES, Leiser JS, Sample JA, Mingoia JT, Hardin AE, Stroud RE, McLean JE, Hendrick JW, Spinale FG.

Ann Thorac Surg. 2004 May;77(5):1684-9; discussion 1689-90.

PMID:
15111166
44.

Pharmacologic inhibition of intracellular caspases after myocardial infarction attenuates left ventricular remodeling: a potentially novel pathway.

Yarbrough WM, Mukherjee R, Escobar GP, Sample JA, McLean JE, Dowdy KB, Hendrick JW, Gibson WC, Hardin AE, Mingoia JT, White PC, Stiko A, Armstrong RC, Crawford FA, Spinale FG.

J Thorac Cardiovasc Surg. 2003 Dec;126(6):1892-9.

45.

Modulation of calcium transport improves myocardial contractility and enzyme profiles after prolonged ischemia-reperfusion.

Yarbrough WM, Mukherjee R, Escobar GP, Hendrick JW, Sample JA, Dowdy KB, McLean JE, Mingoia JT, Crawford FA Jr, Spinale FG.

Ann Thorac Surg. 2003 Dec;76(6):2054-61; discussion 2061.

PMID:
14667641
46.

Direct inhibition of the sodium/hydrogen exchanger after prolonged regional ischemia improves contractility on reperfusion independent of myocardial viability.

Yarbrough WM, Mukherjee R, Escobar GP, Mingoia JT, Sample JA, Hendrick JW, Dowdy KB, McLean JE, Stroud RE, Spinale FG.

J Thorac Cardiovasc Surg. 2003 Nov;126(5):1489-97.

47.

Selective targeting and timing of matrix metalloproteinase inhibition in post-myocardial infarction remodeling.

Yarbrough WM, Mukherjee R, Escobar GP, Mingoia JT, Sample JA, Hendrick JW, Dowdy KB, McLean JE, Lowry AS, O'Neill TP, Spinale FG.

Circulation. 2003 Oct 7;108(14):1753-9. Epub 2003 Sep 15.

PMID:
12975256
48.

Oxytocin synthesis and oxytocin receptor expression by cell lines of human small cell carcinoma of the lung stimulate tumor growth through autocrine/paracrine signaling.

Péqueux C, Breton C, Hendrick JC, Hagelstein MT, Martens H, Winkler R, Geenen V, Legros JJ.

Cancer Res. 2002 Aug 15;62(16):4623-9.

49.

Cardiorenal effects of adenosine subtype 1 (A1) receptor inhibition in an experimental model of heart failure.

Lucas DG Jr, Hendrick JW, Sample JA, Mukherjee R, Escobar GP, Smits GJ, Crawford FA Jr, Spinale FG.

J Am Coll Surg. 2002 May;194(5):603-9.

PMID:
12022600
50.

[Urinary excretion of 6-sulphatoxymelatonin in normal subjects: statistical approach to the influence of age and sex].

Hendrick JC, Crasson M, Hagelstein MT, Bruls E, Legros JJ.

Ann Endocrinol (Paris). 2002 Feb;63(1):3-7. French.

PMID:
11937975

Supplemental Content

Loading ...
Support Center